Media Releases 2011
| 
| 
DECEMBER 2011
19 December 2011 - Multiple Myeloma Trial Planning Underway
15 December 2011 - Suzy Jones Joins the Patrys Board
2 December 2011 - Patrys Announces Oversubscribed Capital Raising of AU$3.4M
NOVEMBER 2011
30 November 2011 - Results of Meeting - AGM 2011
30 November 2011 - CEO's Presentation to AGM 2011
OCTOBER 2011
28 October 2011 - Notice of Annual General Meeting/ Proxy Form
19 October 2011 - Patrys' CEO Dr Marie Roskrow Joins the Board
17 October 2011 - Patrys Update on Large Scale Manufacturing of PAT-SM6
10 October 2011 - CEO Investor Presentation
SEPTEMBER 2011
27 September 2011 - Significant Survival Benefit for PAT-SC1 Treated Patients
26 September 2011 - PAT-SM6 Shows Promise in Multiple Myeloma
20 September 2011 - PAT-SM6 Shows Promise in Additional Cancer Indications
19 September 2011 – Patrys Adds Second Clinical Centre for PAT-SM6 Trial
AUGUST 2011
26 August 2011 – Appendix 4E Preliminary Final Report
22 August 2011 – Patrys' PAT-SM6 Antibody Detected in Patient Tumours
17 August 2011 – Patrys Product Shows Promise in Multiple Myeloma
JULY 2011
25 July 2011 – Patrys Progresses PAT-SM6 Melanoma Trial
JUNE 2011
27 June 2011 – Patrys' PAT-SM6 Inhibits Metastases in Melanoma Cancer Model
22 June 2011 – Patrys CEO Interviews
20 June 2011 – Collaborations Support PAT-SM6 Clinical Program
2 June 2011 – New CEO Investor Presentation
MAY 2011
26 May 2011 – Patrys Confirms Clinical Status - Appoints New CEO
13 May 2011 – Agreement for PAT-LM1 Production Keeps Development on Track
APRIL 2011
13 April 2011 – Patrys Patents Allowed in Major Markets
MARCH 2011
17 March 2011 – Patrys Receives Company of the Year Award
9 March 2011 – International Investor Update Presentation
9 March 2011 – Advances for PAT-SC1 Gastric Cancer Program
8 March 2011 – Biotech Industry’s Interest in PAT-SM6 Target Growing